Relmada Therapeutics share price today

(RLMD)

Relmada Therapeutics share price is $0.36 & ₹30.59 as on 21 Dec 2024, 2.30 'hrs' IST

$0.36

▲

0.01

(2.89%)

Market is closed - opens 8 PM, 23 Dec 2024

View live Relmada Therapeutics share price in Dollar and Rupees. Guide to invest in Relmada Therapeutics from India. Also see the sentimental analysis on Indian investors investing in Relmada Therapeutics. Get details on the Indian mutual funds that are investing in Relmada Therapeutics. Get Analyst recommendations and forecasts along with all the Relmada Therapeutics's financials.

Relmada Therapeutics share price movements

Today's Low: $0.35
Today's High: $0.38
$0.36
2.78%
Downside
Day's Volatility :7.89%
Upside
5.26%
52 Weeks Low: $0.34
52 Weeks High: $7.22
$0.36
5.11%
Downside
52 Weeks Volatility :95.27%
Upside
95.02%

Relmada Therapeutics Returns

Period	Relmada Therapeutics Inc	Sector (Health Care)	Index (Russel 2000)
3 Months	-89.92%	-12.2%	0.0%
6 Months	-88.24%	-6.9%	0.0%
1 Year	-88.47%	2.7%	0.0%
3 Years	-98.33%	-0.2%	-17.3%

Relmada Therapeutics Key Statistics

in dollars & INR

Previous Close	$0.3527
Open	$0.343
Today's High	$0.38
Today's Low	$0.35
Market Capitalization	$10.7M
Today's Volume	$670.8K
52 Week High	$7.2225
52 Week Low	$0.3416
Revenue TTM	$0.0
EBITDA	$-161.2M
Earnings Per Share (EPS)	$-2.86
Profit Margin	0.0%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-100.41%

How to invest in Relmada Therapeutics from India?

It is very easy for Indian residents to invest directly in Relmada Therapeutics from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Relmada Therapeutics stock in both Indian Rupees (INR) and US Dollars (USD). Search for Relmada Therapeutics or RLMD on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Relmada Therapeutics or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Relmada Therapeutics shares which would translate to 2.360 fractional shares of Relmada Therapeutics as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India , including recognised companies like Relmada Therapeutics, in just a few clicks!

Returns in Relmada Therapeutics for Indian investors in Rupees

Investment Value

₹1,00,000

Relmada Therapeutics investment value today

Current value as on today

₹1,90,331

Returns

₹90,331

(+90.33%)

Returns from Relmada Therapeutics Stock

₹88,235 (false-88.24%)

Dollar Returns

₹2,095 (+2.1%)

Indian investors sentiment towards Relmada Therapeutics

21700.0%

Period: Sep 21, 2024 to Dec 20, 2024. Change in 30 Days versus previous period

Investment in Relmada Therapeutics from India has grown in the last 30 days as on Dec 21, 2024. 21700.0% more purchase transactions for Relmada Therapeutics in the last 30 days versus the previous period.

479%

Period: Sep 21, 2024 to Dec 20, 2024. Change in 30 Days versus previous period

Search volume for Relmada Therapeutics on INDmoney from India has grown in the last 30 days as on Dec 21, 2024. 479% more investors are searching Relmada Therapeutics in the last 30 days versus the previous period.

Global Institutional Holdings in Relmada Therapeutics

Franklin Resources Inc
4.32%
Vanguard Group Inc
4.16%
Parsons Capital Management Inc
3.32%
Palo Alto Investors, LLC
2.43%
Deep Track Capital, LP
2.24%
BlackRock Inc
1.90%

Analyst Recommendation on Relmada Therapeutics

Buy

63%Buy

36%Hold

0%Sell

Based on 11 Wall street analysts offering stock ratings for Relmada Therapeutics(by analysts ranked 0 to 5 stars)

Based on 11 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Relmada Therapeutics

What analysts predicted

Upside of 140.75%

Current:

$0.36

Target:

$0.87

Insights on Relmada Therapeutics

Price Movement
In the last 1 month, RLMD stock has moved down by -87.6%
RLMD vs ALNY (1 yr)
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 33.4% return, outperforming this stock by 119.0%
RLMD vs VRTX (3 yr)
In the last 3 years, Vertex Pharmaceuticals Incorporated has given 20.5% return, outperforming this stock by 118.8%

Relmada Therapeutics Technicals Summary

Sell

Neutral

Buy

Relmada Therapeutics is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Relmada Therapeutics Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Relmada Therapeutics Inc	-87.62%	-88.24%	-88.47%	-98.33%	-99.17%
Regeneron Pharmaceuticals, Inc.	-4.72%	-33.43%	-16.35%	14.7%	89.27%
Biontech Se	9.01%	28.55%	5.71%	-57.13%	220.59%
Alnylam Pharmaceuticals, Inc.	-3.99%	7.16%	25.05%	27.48%	103.59%
Vertex Pharmaceuticals Incorporated	-12.1%	-16.49%	-2.12%	78.05%	80.31%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Relmada Therapeutics Inc	NA	NA	NA	-1.72	-1.0	-0.59	NA	2.84
Regeneron Pharmaceuticals, Inc.	17.67	17.67	1.06	45.05	0.17	0.07	NA	272.04
Biontech Se	160.8	NA	0.04	-3.11	-0.02	-0.01	NA	79.73
Alnylam Pharmaceuticals, Inc.	NA	NA	-0.49	-0.19	-15.01	-0.03	NA	0.25
Vertex Pharmaceuticals Incorporated	32.84	NA	1.17	0.54	-0.03	0.12	NA	60.65

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Relmada Therapeutics Inc	Buy	$10.7M	-99.17%	NA	0.0%
Regeneron Pharmaceuticals, Inc.	Buy	$78.5B	89.27%	17.67	33.61%
Biontech Se	Buy	$26.8B	220.59%	160.8	-15.36%
Alnylam Pharmaceuticals, Inc.	Buy	$30.7B	103.59%	NA	-15.86%
Vertex Pharmaceuticals Incorporated	Buy	$115.2B	80.31%	32.84	-4.51%

About Relmada Therapeutics

relmada therapeutics (otcqb: rlmd) is a clinical-stage, publicly traded specialty pharmaceutical company developing novel versions of proven drug products together with new chemical entities that potentially address areas of high unmet medical need in the treatment of chronic pain. relmada has a diversified portfolio of four lead products at various stages of development including d-methadone (rel-1017) its n-methyl-d-aspartate (nmda) receptor antagonist for neuropathic pain; topical mepivacaine (rel-1021), its orphan drug designated topical formulation of the local anesthetic mepivacaine; oral buprenorphine (rel-1028) its oral dosage form of the opioid analgesic buprenorphine; and levocap er (rel-1015), its abuse resistant, sustained release dosage form of the opioid analgesic levorphanol. relmada’s product development efforts are guided by the internationally recognized scientific expertise of our research team. relmada’s approach is expected to reduce clinical development risks and

Organization	Relmada Therapeutics
Employees	20
CEO	Dr. Sergio Traversa M.B.A., Pharm.D.
Industry	Pharmaceuticals: Major

Management People of Relmada Therapeutics

Name	Title
Dr. Sergio Traversa M.B.A., Pharm.D.	CEO & Director
Mr. Maged S. Shenouda M.B.A., R.Ph.	Chief Financial Officer
Mr. Charles S. Ence CPA, M.B.A.	Chief Accounting & Compliance Officer
Dr. Paolo Manfredi M.D., Ph.D.	Chief Scientific Officer
Ms. Gina DiGuglielmo	VP & Head of Clinical Operations
Dr. Marco Pappagallo M.D.	Chief Clinical Officer
Mr. John Hixon	Head of Commercial
Dr. Andrew Cutler	Senior Clinical Development Advisor
Dr. Richard M. Mangano	Consultant

Important FAQs about investing in Relmada Therapeutics from India :

What is Relmada Therapeutics share price today?

Relmada Therapeutics share price today stands at $0.36, Open: $0.34 ; Previous Close: $0.35 ; High: $0.38 ; Low: $0.35 ; 52 Week High: $7.22 ; 52 Week Low: $0.34. The stock opens at $0.34, after a previous close of $0.35. The stock reached a daily high of $0.38 and a low of $0.35, with a 52-week high of $7.22 and a 52-week low of $0.34.

Can Indians buy Relmada Therapeutics shares?

Yes, Indians can invest in the Relmada Therapeutics (RLMD) from India.

With INDmoney, you can buy Relmada Therapeutics at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Relmada Therapeutics at zero transaction cost.

How can I buy Relmada Therapeutics shares from India?

It is very easy to buy Relmada Therapeutics from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Relmada Therapeutics be purchased?

Yes, you can buy fractional shares of Relmada Therapeutics with INDmoney app.

What are the documents required to start investing in Relmada Therapeutics stocks?

To start investing in Relmada Therapeutics, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.